| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |